News Image

Palvella Therapeutics Announces Abstract Highlighting the Estimated Diagnosed Prevalence and Annual Incidence of Lymphatic Malformations in the U.S. Accepted for Poster Presentation at the 82nd Annual Meeting of the Society for Investigative Dermatology

Provided By GlobeNewswire

Last update: Apr 23, 2025

Quantitative analysis of medical claims indicates an estimated 44,553 to 92,967 diagnosed U.S. patients with lymphatic malformations (LMs) with cutaneous involvement

Read more at globenewswire.com

PALVELLA THERAPEUTICS INC

NASDAQ:PVLA (6/3/2025, 4:04:08 PM)

24.44

-0.7 (-2.78%)



Find more stocks in the Stock Screener

Follow ChartMill for more